Earth Science Tech (ETST) Operating Margin (2011 - 2026)
Earth Science Tech (ETST) posted Operating Margin of 12.03% for Q1 2026, down 24.84% on a QoQ basis from 16.0% in Q4 2025, and down 327.0% year-over-year from 5.3% in Q1 2025.
Earth Science Tech (ETST) Operating Margin (2011 - 2026) Analysis & Trends
Earth Science Tech's Operating Margin history runs 15 years deep, the most recent figure standing at 12.03% for Q1 2026.
- Quarterly Operating Margin fell 327.0% year-over-year to 12.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.27% (down 114.0% YoY) and the FY2026 annual result came in at 9.27%, down 114.0% from the prior year.
- Operating Margin was 12.03% for Q1 2026 at Earth Science Tech, down from 16.0% in the prior quarter.
- Across five years, Operating Margin topped out at 24.9% in Q3 2023 and bottomed at 37581.77% in Q1 2022.
- A 5-year average of 2642.96% and a median of 6.1% in 2023 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2022 — Operating Margin tumbled 3654438 bps — and 2023, when it jumped 3732239 bps.
- Earth Science Tech's Operating Margin stood at 1905.84% in 2022, then surged by 100 bps to 6.1% in 2023, then slumped by 50 bps to 3.08% in 2024, then surged by 420 bps to 16.0% in 2025, then declined by 25 bps to 12.03% in 2026.
- Business Quant data shows ETST's Operating Margin at 12.03% in Q1 2026, 16.0% in Q4 2025, and 6.44% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn | 12.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.03% |
| Dec 31, 2025 | 16.00% |
| Sep 30, 2025 | 6.44% |
| Jun 30, 2025 | 2.76% |
| Mar 31, 2025 | 15.30% |
| Dec 31, 2024 | 3.08% |
| Sep 30, 2024 | 9.74% |
| Jun 30, 2024 | 12.43% |
| Mar 31, 2024 | 4.30% |
| Dec 31, 2023 | 6.10% |
| Sep 30, 2023 | 24.90% |
| Jun 30, 2023 | -10.45% |
| Mar 31, 2023 | -259.38% |
| Dec 31, 2022 | -1,905.84% |
| Mar 31, 2022 | -37,581.77% |
| Dec 31, 2021 | -2,525.67% |
| Sep 30, 2021 | -1,881.47% |
| Jun 30, 2021 | -154.10% |
| Mar 31, 2021 | -1,037.38% |
| Dec 31, 2020 | -340.38% |